Thanks to the ever-growing technology, the laser technology has come a long way. One of the major uses of lasers is flow cytometry, which is basically a laser-based technique that used for studying the characteristics or fluorescence intensity of cells in a fluid when it passes through a beam of laser. This technology is widely used in life sciences as well as biomedical sciences for research and clinical purposes, mainly because it is quick, accurate, and allows the researchers to collect data relating to multiple parameters of the cell. Thus, increasing use of this technology is has driven the growth of the flow cytometry market, globally.
The report “Flow Cytometry Market by Technology (Cell & Bead-based), Product & Services (Analyzer, Sorter, Reagents), Application (Research (Cell Analysis), Clinical (Cancer, HIV)), End User (Academia, Research Institute, Hospital) – Global Forecast to 2022″, The global flow cytometry market is expected to reach USD 4.79 Billion by 2022 from USD 3.29 Billion in 2017, at a CAGR of 7.8%.
Know more : https://www.marketsandmarkets.com/pdfdownload.asp?id=65374584
Driving Factors and Challenges
The global market for flow cytometry is primarily driven by the following factors:
- Technological developments in flow cytometry instruments
- Increasing applications of flow cytometry
- Increase in research activities in life sciences and growing clinical trials
- Rising cases of HIV and cancer
- Launching of new reagents for applications as well as user-friendly and intuitive software
Moreover, upcoming markets in China and India, developing of high throughput flow cytometry, and more focus on stem cells research is expected to stimulate the growth of this market even further. Furthermore, rising number of diseases and patients, increased research activities, increasing focus of leading market players, and government support are some of the factors driving the growth of this market in Asia-Pacific.
Download FREE PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=65374584
By end user, the market is segmented into academic and research institutes, hospitals and clinical testing laboratories, and pharmaceutical and biotechnology companies. The academic and research institutes end-user segment is expected to account for the largest share of the flow cytometry market in 2017 due to the growing use of flow cytometry for research in cancer, stem cell, and HIV; increasing number of cancer and stem cell research projects across the globe; and increasing public-private funding for flow cytometry-based research.
